secwatch.observer — SEC 8-K summary
======================================

Issuer:     Humacyte, Inc. (HUMA)
CIK:        0001818382
Form:       8-K
Filed at:   2025-10-07T23:59:59+00:00
Accession:  0001104659-25-097591
Event type: other_material
Sentiment:  neutral
Materiality: 0.70
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Humacyte prices $60M registered direct offering of common stock and warrants
----------------------------------------------------------------------------

- Raised $60.0M via sale of 28.4M shares and warrants to purchase 28.4M shares at $2.11 per unit.
- Warrants exercisable at $2.11, become exercisable 180 days after issuance, expire April 7, 2031.
- Offering oversubscribed with institutional investors; expected to close October 8, 2025.
- D. Boral Capital acting as exclusive placement agent; fee equal to 5.75% of gross proceeds.
- Offered under effective shelf registration statement (File No. 333-290231) declared effective Sept 22, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1818382/000110465925097591/0001104659-25-097591-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1818382/000110465925097591/tm2528189d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-097591

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer